Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Obstructive Pulmonary Disease01:22

Chronic Obstructive Pulmonary Disease

2.3K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.3K
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

597
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
597
Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

3.6K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
3.6K
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

3.1K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
3.1K
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

578
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
578
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

4.3K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
4.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Re: Testosterone Treatment in Prostate Cancer Survivors with Hypogonadism: A Randomized Clinical Trial.

European urology·2026
Same author

Potential Donors' Awareness and Perceived Feasibility of Donating Human Milk in Australia.

Maternal & child nutrition·2026
Same author

Higher Serum Testosterone Protects Against the Development of Type 2 Diabetes in Middle-Aged but Not Older Men.

Diabetes, obesity & metabolism·2026
Same author

Histopathological characteristics of screen-detected colorectal cancers.

Virchows Archiv : an international journal of pathology·2026
Same author

Masculine Norm Adherence Among Australian Men: Latent Structure of the CMNI-22 and Its Links With Mental Health Outcomes.

Health promotion journal of Australia : official journal of Australian Association of Health Promotion Professionals·2026
Same author

Relationships between pre-pandemic mental health, sociodemographic factors and health behaviours in older adults during the acute onset of COVID-19 in Australia: A descriptive analysis.

PloS one·2026

Related Experiment Video

Updated: Jan 22, 2026

Assessment of Vascular Function in Patients With Chronic Kidney Disease
08:50

Assessment of Vascular Function in Patients With Chronic Kidney Disease

Published on: June 16, 2014

16.7K

Measuring Masculinity in Men With Chronic Disease.

Stefano Occhipinti1, Kirstyn Laurie1,2, Melissa K Hyde1

  • 11 Menzies Health Institute Queensland, Griffith University, Gold Coast, Australia.

American Journal of Men'S Health
|July 4, 2019
PubMed
Summary

The Masculinity in Chronic Disease Inventory (MCD-I) is validated for men with chronic diseases. It measures internalized masculine beliefs and can guide gender-sensitive men's health services.

Keywords:
chronic diseasemasculinitymen’s healthsexual health

More Related Videos

Author Spotlight: Efficacy of Auricular Pressure Bean Therapy in Reducing Wheezing Symptoms
02:34

Author Spotlight: Efficacy of Auricular Pressure Bean Therapy in Reducing Wheezing Symptoms

Published on: May 10, 2024

1.9K
Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure
08:17

Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure

Published on: August 25, 2017

11.5K

Related Experiment Videos

Last Updated: Jan 22, 2026

Assessment of Vascular Function in Patients With Chronic Kidney Disease
08:50

Assessment of Vascular Function in Patients With Chronic Kidney Disease

Published on: June 16, 2014

16.7K
Author Spotlight: Efficacy of Auricular Pressure Bean Therapy in Reducing Wheezing Symptoms
02:34

Author Spotlight: Efficacy of Auricular Pressure Bean Therapy in Reducing Wheezing Symptoms

Published on: May 10, 2024

1.9K
Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure
08:17

Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure

Published on: August 25, 2017

11.5K

Area of Science:

  • Men's Health
  • Psychological Assessment
  • Chronic Illness Management

Background:

  • Internalized masculine beliefs influence men's health behaviors.
  • The Masculinity in Chronic Disease Inventory (MCD-I) was previously validated for prostate cancer patients.
  • Broader validation is needed for diverse chronic disease populations.

Purpose of the Study:

  • To assess the validity of the MCD-I in men with various chronic diseases.
  • To explore the MCD-I's applicability beyond prostate cancer.
  • To examine the MCD-I's relationship with sexual health and age.

Main Methods:

  • Cross-sectional survey of 633 men (aged 47-93) with chronic conditions.
  • Utilized the MCD-I and Erectile Function measures.
  • Performed exploratory and confirmatory factor analyses and discriminant validity tests.

Main Results:

  • A five-factor structure of the MCD-I was confirmed, explaining 60% of the variance.
  • Reliabilities for MCD-I domains ranged from good to excellent (α = 0.68-0.93).
  • The MCD-I demonstrated sensitivity to age and sexual health status.

Conclusions:

  • The MCD-I is a valid measure of internalized masculine beliefs for men with chronic diseases.
  • Findings support the MCD-I's wider application in men's health research and practice.
  • MCD-I results can inform gender-sensitive health interventions for men.